AAPL316.22+2.83 (+0.90%) ▲|ABBV249.91-2.83 (-1.12%) ▼|ABT94.40-0.78 (-0.82%) ▼|ACN139.06+3.50 (+2.58%) ▲|ADBE222.65+1.71 (+0.77%) ▲|AMAT588.66+18.16 (+3.18%) ▲|AMD546.72+29.32 (+5.67%) ▲|AMGN363.62-4.37 (-1.19%) ▼|AMT165.00-0.04 (-0.02%) ▼|AMZN247.04+3.42 (+1.40%) ▲|AVGO401.11+12.42 (+3.20%) ▲|AXP346.72+10.33 (+3.07%) ▲|BA223.11-1.84 (-0.82%) ▼|BAC59.25+0.95 (+1.63%) ▲|BKNG175.52+1.23 (+0.71%) ▲|BLK1,019.68+29.34 (+2.96%) ▲|BMY57.94+0.40 (+0.70%) ▲|BNY152.26+2.12 (+1.41%) ▲|BRK-B495.45+0.66 (+0.13%) ▲|C139.57+2.18 (+1.59%) ▲|CAT938.39-9.69 (-1.02%) ▼|CL91.01-2.03 (-2.18%) ▼|CMCSA23.35+0.16 (+0.67%) ▲|COF200.10+8.15 (+4.25%) ▲|COP108.02-2.70 (-2.44%) ▼|COST912.97-40.16 (-4.21%) ▼|CRM162.50-4.08 (-2.45%) ▼|CSCO118.31+4.49 (+3.94%) ▲|CVS102.81-1.66 (-1.59%) ▼|CVX174.05-1.92 (-1.09%) ▼|DE592.90-3.84 (-0.64%) ▼|DHR195.98+5.21 (+2.73%) ▲|DIS96.17-0.53 (-0.55%) ▼|DUK125.26-1.53 (-1.21%) ▼|EMR137.80+1.32 (+0.97%) ▲|FDX310.84+1.08 (+0.35%) ▲|GD374.60+0.29 (+0.08%) ▲|GE359.04+3.01 (+0.85%) ▲|GEV1,075.26+4.27 (+0.40%) ▲|GILD134.84-0.98 (-0.72%) ▼|GM76.65+0.41 (+0.54%) ▲|GOOG356.24-2.47 (-0.69%) ▼|GOOGL358.89-3.03 (-0.84%) ▼|GS1,055.97+26.33 (+2.56%) ▲|HD338.73+2.52 (+0.75%) ▲|HON223.42+3.06 (+1.39%) ▲|IBM295.30-6.75 (-2.23%) ▼|INTC112.54+2.30 (+2.09%) ▲|INTU273.38+1.28 (+0.47%) ▲|ISRG411.55-3.55 (-0.86%) ▼|JNJ259.10-4.30 (-1.63%) ▼|JPM335.47+4.85 (+1.47%) ▲|KO82.63-0.77 (-0.92%) ▼|LIN525.56-2.11 (-0.40%) ▼|LLY1,216.95+1.12 (+0.09%) ▲|LMT518.26-9.70 (-1.84%) ▼|LOW213.00+0.15 (+0.07%) ▲|LRCX353.17+20.02 (+6.01%) ▲|MA523.20+4.21 (+0.81%) ▲|MCD276.49-1.76 (-0.63%) ▼|MDLZ58.30-1.18 (-1.98%) ▼|MDT82.39+0.38 (+0.46%) ▲|META631.48+28.36 (+4.70%) ▲|MMM155.34+0.64 (+0.41%) ▲|MO71.59-1.22 (-1.68%) ▼|MRK125.07-0.92 (-0.73%) ▼|MS222.13+4.06 (+1.86%) ▲|MSFT384.36+1.02 (+0.27%) ▲|MU991.64+42.84 (+4.52%) ▲|NEE87.10-0.34 (-0.39%) ▼|NFLX75.47-0.12 (-0.16%) ▼|NKE42.78-0.11 (-0.26%) ▼|NOW108.84+1.06 (+0.98%) ▲|NVDA202.78-1.34 (-0.66%) ▼|ORCL144.22+3.73 (+2.66%) ▲|PEP137.86-4.64 (-3.25%) ▼|PFE24.25+0.20 (+0.83%) ▲|PG146.85-1.55 (-1.04%) ▼|PLTR129.04-3.18 (-2.41%) ▼|PM181.17-5.90 (-3.15%) ▼|QCOM191.11+4.55 (+2.44%) ▲|RTX195.20+0.29 (+0.15%) ▲|SBUX106.41+2.54 (+2.45%) ▲|SCHW101.91+0.21 (+0.21%) ▲|SO95.17-1.21 (-1.26%) ▼|SPG219.71+0.62 (+0.28%) ▲|T21.04-0.08 (-0.38%) ▼|TMO524.71+14.58 (+2.86%) ▲|TMUS181.48+1.34 (+0.74%) ▲|TSLA406.55+12.62 (+3.20%) ▲|TXN308.53+7.21 (+2.39%) ▲|UBER74.35+0.75 (+1.02%) ▲|UNH431.68+6.08 (+1.43%) ▲|UNP285.04+4.10 (+1.46%) ▲|UPS110.74+0.80 (+0.73%) ▲|USB61.90+0.90 (+1.48%) ▲|V348.20+0.67 (+0.19%) ▲|VZ42.24-0.21 (-0.49%) ▼|WFC86.91+1.35 (+1.58%) ▲|WMT112.21-0.89 (-0.79%) ▼|XOM137.46-3.67 (-2.60%) ▼|AAPL316.22+2.83 (+0.90%) ▲|ABBV249.91-2.83 (-1.12%) ▼|ABT94.40-0.78 (-0.82%) ▼|ACN139.06+3.50 (+2.58%) ▲|ADBE222.65+1.71 (+0.77%) ▲|AMAT588.66+18.16 (+3.18%) ▲|AMD546.72+29.32 (+5.67%) ▲|AMGN363.62-4.37 (-1.19%) ▼|AMT165.00-0.04 (-0.02%) ▼|AMZN247.04+3.42 (+1.40%) ▲|AVGO401.11+12.42 (+3.20%) ▲|AXP346.72+10.33 (+3.07%) ▲|BA223.11-1.84 (-0.82%) ▼|BAC59.25+0.95 (+1.63%) ▲|BKNG175.52+1.23 (+0.71%) ▲|BLK1,019.68+29.34 (+2.96%) ▲|BMY57.94+0.40 (+0.70%) ▲|BNY152.26+2.12 (+1.41%) ▲|BRK-B495.45+0.66 (+0.13%) ▲|C139.57+2.18 (+1.59%) ▲|CAT938.39-9.69 (-1.02%) ▼|CL91.01-2.03 (-2.18%) ▼|CMCSA23.35+0.16 (+0.67%) ▲|COF200.10+8.15 (+4.25%) ▲|COP108.02-2.70 (-2.44%) ▼|COST912.97-40.16 (-4.21%) ▼|CRM162.50-4.08 (-2.45%) ▼|CSCO118.31+4.49 (+3.94%) ▲|CVS102.81-1.66 (-1.59%) ▼|CVX174.05-1.92 (-1.09%) ▼|DE592.90-3.84 (-0.64%) ▼|DHR195.98+5.21 (+2.73%) ▲|DIS96.17-0.53 (-0.55%) ▼|DUK125.26-1.53 (-1.21%) ▼|EMR137.80+1.32 (+0.97%) ▲|FDX310.84+1.08 (+0.35%) ▲|GD374.60+0.29 (+0.08%) ▲|GE359.04+3.01 (+0.85%) ▲|GEV1,075.26+4.27 (+0.40%) ▲|GILD134.84-0.98 (-0.72%) ▼|GM76.65+0.41 (+0.54%) ▲|GOOG356.24-2.47 (-0.69%) ▼|GOOGL358.89-3.03 (-0.84%) ▼|GS1,055.97+26.33 (+2.56%) ▲|HD338.73+2.52 (+0.75%) ▲|HON223.42+3.06 (+1.39%) ▲|IBM295.30-6.75 (-2.23%) ▼|INTC112.54+2.30 (+2.09%) ▲|INTU273.38+1.28 (+0.47%) ▲|ISRG411.55-3.55 (-0.86%) ▼|JNJ259.10-4.30 (-1.63%) ▼|JPM335.47+4.85 (+1.47%) ▲|KO82.63-0.77 (-0.92%) ▼|LIN525.56-2.11 (-0.40%) ▼|LLY1,216.95+1.12 (+0.09%) ▲|LMT518.26-9.70 (-1.84%) ▼|LOW213.00+0.15 (+0.07%) ▲|LRCX353.17+20.02 (+6.01%) ▲|MA523.20+4.21 (+0.81%) ▲|MCD276.49-1.76 (-0.63%) ▼|MDLZ58.30-1.18 (-1.98%) ▼|MDT82.39+0.38 (+0.46%) ▲|META631.48+28.36 (+4.70%) ▲|MMM155.34+0.64 (+0.41%) ▲|MO71.59-1.22 (-1.68%) ▼|MRK125.07-0.92 (-0.73%) ▼|MS222.13+4.06 (+1.86%) ▲|MSFT384.36+1.02 (+0.27%) ▲|MU991.64+42.84 (+4.52%) ▲|NEE87.10-0.34 (-0.39%) ▼|NFLX75.47-0.12 (-0.16%) ▼|NKE42.78-0.11 (-0.26%) ▼|NOW108.84+1.06 (+0.98%) ▲|NVDA202.78-1.34 (-0.66%) ▼|ORCL144.22+3.73 (+2.66%) ▲|PEP137.86-4.64 (-3.25%) ▼|PFE24.25+0.20 (+0.83%) ▲|PG146.85-1.55 (-1.04%) ▼|PLTR129.04-3.18 (-2.41%) ▼|PM181.17-5.90 (-3.15%) ▼|QCOM191.11+4.55 (+2.44%) ▲|RTX195.20+0.29 (+0.15%) ▲|SBUX106.41+2.54 (+2.45%) ▲|SCHW101.91+0.21 (+0.21%) ▲|SO95.17-1.21 (-1.26%) ▼|SPG219.71+0.62 (+0.28%) ▲|T21.04-0.08 (-0.38%) ▼|TMO524.71+14.58 (+2.86%) ▲|TMUS181.48+1.34 (+0.74%) ▲|TSLA406.55+12.62 (+3.20%) ▲|TXN308.53+7.21 (+2.39%) ▲|UBER74.35+0.75 (+1.02%) ▲|UNH431.68+6.08 (+1.43%) ▲|UNP285.04+4.10 (+1.46%) ▲|UPS110.74+0.80 (+0.73%) ▲|USB61.90+0.90 (+1.48%) ▲|V348.20+0.67 (+0.19%) ▲|VZ42.24-0.21 (-0.49%) ▼|WFC86.91+1.35 (+1.58%) ▲|WMT112.21-0.89 (-0.79%) ▼|XOM137.46-3.67 (-2.60%) ▼|
26 C
New York
Thursday, July 9, 2026

Tag: press

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.

From Gaza to Africa: Equalall widens its Urgent Global Fundraising Drive to Support Crisis-Affected Communities in Africa

Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan
Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan

Sodexo Q3 Fiscal 2025 revenues in line with expectations

Issy-les-Moulineaux, July 1, 2025 (7am)
Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)

Baidu Announces Management Changes

BEIJING, July 1, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading...

[Anime Expo 2025] NOMELON NOLEMON (tsumiki and MIKIMARIA) to Perform Live During “Mobile Suit Gundam GQuuuuuuX” Panel Livestream

Onsite Free Giveaway and GUNDAM CARD GAME Promotional Tie-In Details Revealed LOS ANGELES, June 30, 2025 /PRNewswire/ -- Today, Bandai Namco Filmworks Inc. announced the...

Product of the Year Malaysia Shares Highlights from Malaysia 2025 Awards Coverage

In a time when credibility is more important than ever, Voted Product of the Year stands apart by putting the power in the hands of consumers.

DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp.

Combined Company Expected to be Listed on NASDAQ Global Market

Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible debentures of the Company, as further described herein.

THE PURPOSE-DRIVEN TRAVELER: NEW REPORT REVEALS SHIFT IN ASIA PACIFIC LUXURY TRAVEL TRENDS

The Luxury Group by Marriott International launches 'The Intentional Traveler' report, unveiling evolving behaviors among high-net-worth travelers across seven markets Wellness plays key role in destination choice, with...

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an underwritten public offering of 24,242,425 shares of its common stock at a public offering price of $8.25 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be $200.0 million. All shares in the offering are being sold by Dyne. The offering is expected to close on or about July 2, 2025, subject to customary closing conditions. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 3,636,363 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

NMP Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Palo Alto, California, June 30, 2025 (GLOBE NEWSWIRE) --  NMP Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Company’s initial business combination. In connection with the offering, $10.00 per unit will be deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee. Up to $300,000 of interest earned on the funds held in the trust account, in the aggregate, may be released to us to fund our working capital requirements.  In addition, we may withdraw interest earned on the trust to pay our income and franchise taxes, if any. The units are expected to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “NMPAU” beginning on July 1, 2025. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to trade on Nasdaq under the symbols “NMP” and “NMPAR,” respectively.

Oliveda International, Inc. (OLVI) Subsidiary Olive Tree People Canada Inc. Brings Its Waterless Beauty to Canada in July 2025

SANTA MONICA, CA, June 30, 2025 (GLOBE NEWSWIRE) -- Oliveda International, Inc. (OTC Pink: OLVI) today announced that after a true waterless beauty movement emerged in the United States within just two years, with over 60,000 waterless beauty consultants, and Olive Tree People USA Inc. exploded from 40 to over 10,000 packages per day and up to 4 million in sales per day in 2024 alone, olive farmer and CEO Thomas Lommel has set the course for global expansion by establishing subsidiaries in Canada and Europe.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress